Gilead stock falls after disappointing early trial results for highly anticipated coronavirus treatment

Gilead stock falls after disappointing early trial results for highly anticipated coronavirus treatment

Stock trading was briefly halted Thursday for California-based Gilead Sciences, after a draft report said the company’s experimental coronavirus treatment disappointed in a recent drug trial. Shares continued to slump, even after the biotech company moved quickly to dispute the findings of the World Health Organization study into the effectiveness of its anti-viral drug, remdesivir. […]